SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001808805-22-000079
Filing Date
2022-08-02
Accepted
2022-08-01 17:38:43
Documents
14
Period of Report
2022-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K naut-20220802.htm   iXBRL 8-K 39133
2 EX-99.1 exhibit991-2022q28xk.htm EX-99.1 99668
  Complete submission text file 0001808805-22-000079.txt   311397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT naut-20220802.xsd EX-101.SCH 2156
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT naut-20220802_def.xml EX-101.DEF 4823
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT naut-20220802_lab.xml EX-101.LAB 27109
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT naut-20220802_pre.xml EX-101.PRE 16843
8 EXTRACTED XBRL INSTANCE DOCUMENT naut-20220802_htm.xml XML 15457
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 221126031
SIC: 3826 Laboratory Analytical Instruments